TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | ---- | ---- | -38.75%44.97B | ---- | ---- | ---- | 4.36%73.42B | ---- | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | ---- | ---- | 16.08%-3B | ---- | ---- | ---- | 6.50%-3.57B | ---- | ---- |
Dividend (income)- adjustment | ---- | ---- | ---- | -11.95%-46.67M | ---- | ---- | ---- | 29.11%-41.68M | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | ---- | ---- | -107.59%-58.93M | ---- | ---- | ---- | 115.89%776.61M | ---- | ---- |
Impairment and provisions: | ---- | ---- | ---- | 315.12%3.87B | ---- | ---- | ---- | -75.44%931.73M | ---- | ---- |
-Impairmen of inventory (reversal) | ---- | ---- | ---- | 675.86%3.49B | ---- | ---- | ---- | -85.58%449.82M | ---- | ---- |
-Impairment of trade receivables (reversal) | ---- | ---- | ---- | -21.59%377.88M | ---- | ---- | ---- | 71.81%481.92M | ---- | ---- |
Revaluation surplus: | ---- | ---- | ---- | -6,817.08%-340.11M | ---- | ---- | ---- | -28.82%-4.92M | ---- | ---- |
-Other fair value changes | ---- | ---- | ---- | -6,817.08%-340.11M | ---- | ---- | ---- | -28.82%-4.92M | ---- | ---- |
Asset sale loss (gain): | ---- | ---- | ---- | 44.22%-2.59B | ---- | ---- | ---- | -175.71%-4.65B | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | 14.90%-10.86M | ---- | ---- | ---- | 33.69%-12.76M | ---- | ---- |
-Loss (gain) from selling other assets | ---- | ---- | ---- | 44.30%-2.58B | ---- | ---- | ---- | -178.12%-4.64B | ---- | ---- |
Depreciation and amortization: | ---- | ---- | ---- | -2.36%9.08B | ---- | ---- | ---- | 15.34%9.3B | ---- | ---- |
-Depreciation | ---- | ---- | ---- | -2.36%9.08B | ---- | ---- | ---- | 15.34%9.3B | ---- | ---- |
Financial expense | ---- | ---- | ---- | -1.26%4.84B | ---- | ---- | ---- | -27.32%4.91B | ---- | ---- |
Exchange Loss (gain) | ---- | ---- | ---- | 561.67%553.44M | ---- | ---- | ---- | -1,494.55%-119.88M | ---- | ---- |
Special items | ---- | ---- | ---- | 16.71%893.78M | ---- | ---- | ---- | -31.13%765.8M | ---- | ---- |
Operating profit before the change of operating capital | ---- | ---- | ---- | -28.81%58.17B | ---- | ---- | ---- | 2.64%81.71B | ---- | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---- | ---- | 19.18%234.18B | ---- | ---- | ---- | 613.12%196.5B | ---- | ---- |
Accounts receivable (increase)decrease | ---- | ---- | ---- | 564.07%18.85B | ---- | ---- | ---- | 125.18%2.84B | ---- | ---- |
Accounts payable increase (decrease) | ---- | ---- | ---- | -15.16%-277.48B | ---- | ---- | ---- | -2,284.20%-240.96B | ---- | ---- |
Cash from business operations | -84.18%4.37B | -84.03%3.47B | -138.46%-4.38B | -15.91%33.71B | 0.87%27.61B | -30.90%21.72B | 291.88%11.38B | -2.39%40.09B | -12.45%27.37B | -8.32%31.43B |
Other taxs | 66.34%-9.22B | 56.46%-8.64B | -15.10%-5.04B | 20.19%-29.8B | 13.22%-27.38B | 14.22%-19.85B | 40.20%-4.38B | -1.03%-37.34B | -5.00%-31.55B | 15.85%-23.14B |
Net cash from operations | -2,159.99%-4.85B | -377.63%-5.18B | -234.57%-9.42B | 42.24%3.91B | 105.64%235.32M | -77.50%1.86B | 152.80%7B | -33.13%2.75B | -442.36%-4.18B | 22.21%8.29B |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | ---- | ---- | -0.41%2.52B | ---- | ---- | ---- | -42.77%2.53B | ---- | ---- |
Sale of fixed assets | ---- | ---- | ---- | 343.57%345.25M | ---- | ---- | ---- | 22.44%77.83M | ---- | ---- |
Purchase of fixed assets | 16.99%-4.11B | 16.14%-2.47B | 36.65%-1.17B | 35.02%-8.33B | 30.99%-4.96B | 42.81%-2.94B | -76.30%-1.85B | -33.92%-12.83B | -60.74%-7.18B | -111.35%-5.15B |
Sale of subsidiaries | ---- | ---- | ---- | -51.07%711.06M | ---- | ---- | ---- | -54.89%1.45B | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | 78.59%-1.79B | ---- | ---- | ---- | 47.33%-8.38B | ---- | ---- |
Recovery of cash from investments | ---- | ---- | ---- | -27.21%10.57B | ---- | ---- | ---- | 108.61%14.53B | ---- | ---- |
Cash on investment | ---- | ---- | ---- | 17.02%-8.64B | ---- | ---- | ---- | 32.66%-10.41B | ---- | ---- |
Other items in the investment business | 255.35%9.74B | 180.94%7.44B | 124.00%3.39B | ---- | 169.03%2.74B | 802.08%2.65B | -37.64%1.51B | ---- | 82.80%-3.97B | 106.49%293.71M |
Net cash from investment operations | 354.45%5.63B | 1,795.70%4.98B | 758.69%2.22B | 64.58%-4.62B | 80.16%-2.21B | 93.95%-293.42M | -124.45%-337.01M | 50.42%-13.03B | 59.53%-11.15B | 30.26%-4.85B |
Net cash before financing | 139.63%783.85M | -112.78%-200.81M | -208.06%-7.2B | 93.16%-703.32M | 87.10%-1.98B | -54.27%1.57B | 156.09%6.66B | 53.63%-10.28B | 41.81%-15.33B | 2,043.74%3.44B |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | ---- | ---- | -35.55%91.75B | ---- | ---- | ---- | 16.48%142.35B | ---- | ---- |
Refund | ---- | ---- | ---- | 12.37%-88.4B | ---- | ---- | ---- | 11.97%-100.87B | ---- | ---- |
Issuing shares | ---- | ---- | ---- | --3.46B | ---- | ---- | ---- | ---- | ---- | ---- |
Interest paid - financing | ---- | ---- | ---- | 8.88%-893.78M | ---- | ---- | ---- | 11.79%-980.91M | ---- | ---- |
Dividends paid - financing | 53.10%-13.44B | 38.07%-9.18B | 12.46%-4.46B | -3.34%-34.27B | 0.98%-28.65B | -50.54%-14.82B | -60.24%-5.09B | 20.20%-33.17B | 16.16%-28.93B | 24.71%-9.85B |
Absorb investment income | ---- | ---- | ---- | -41.53%8.4B | ---- | ---- | ---- | -62.95%14.37B | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.29B | ---- | ---- |
Other items of the financing business | -159.31%-6.97B | 243.69%2.32B | -434.53%-4.49B | 2.09%-15.14B | -114.56%-2.69B | -151.97%-1.62B | -88.38%1.34B | 39.42%-15.47B | 33.10%18.47B | -78.69%3.11B |
Net cash from financing operations | 34.88%-20.41B | 58.28%-6.86B | -138.52%-8.94B | -1,170.49%-36.81B | -199.45%-31.33B | -143.99%-16.44B | -144.82%-3.75B | 114.88%3.44B | 49.28%-10.46B | -545.39%-6.74B |
Effect of rate | -94.65%7.05M | -31.56%102.96M | 190.81%26.22M | -93.83%34.39M | -85.21%131.65M | -70.03%150.43M | -111.26%-28.87M | 75.48%557.11M | 4,029.99%889.91M | 4,050.16%501.87M |
Net Cash | 41.10%-19.62B | 52.52%-7.06B | -654.03%-16.15B | -448.41%-37.52B | -29.15%-33.31B | -350.23%-14.87B | 182.93%2.91B | 84.89%-6.84B | 45.09%-25.79B | -347.18%-3.3B |
Begining period cash | -27.88%96.94B | -27.88%96.94B | -27.88%96.94B | -4.47%134.42B | -4.47%134.42B | -4.47%134.42B | -4.47%134.42B | -24.21%140.71B | -24.21%140.71B | -24.21%140.71B |
Cash at the end | -23.62%77.33B | -24.83%89.99B | -41.14%80.82B | -27.88%96.94B | -12.57%101.24B | -13.20%119.71B | -0.10%137.31B | -4.47%134.42B | -16.49%115.81B | -26.25%137.91B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | KPMG | -- | -- | -- | KPMG | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.